These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29787664)

  • 1. [COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].
    Vasil'eva EV; Kondrakhin EA; Salimov RM; Kovalev GI
    Eksp Klin Farmakol; 2016; 79(9):3-11. PubMed ID: 29787664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of piracetam on behavior and brain receptors in C57BL/6 and BALB/c mice: nootropic and anxiolytic effects].
    Kovalev GI; Kondrakhin EA; Salimov RM; Neznamov GG
    Eksp Klin Farmakol; 2013; 76(9):3-10. PubMed ID: 24432561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study].
    Narkevich VB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Kozlovskaia MM; Maĭskiĭ AI; Raevskiĭ KS
    Eksp Klin Farmakol; 2008; 71(5):8-12. PubMed ID: 19093364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank].
    Kozlovskiĭ II; Andreeva LA; Kozlovskaia MM; Nadorova AV; Kolik LG
    Eksp Klin Farmakol; 2012; 75(2):10-3. PubMed ID: 22550852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.
    Vyunova TV; Andreeva L; Shevchenko K; Myasoedov N
    Protein Pept Lett; 2018; 25(10):914-923. PubMed ID: 30255741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic activity of the neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB/c and C57BL/6 mice.
    Zolotarev YA; Kovalev GI; Kost NV; Voevodina ME; Sokolov OY; Dadayan AK; Kondrakhin EA; Vasileva EV; Bogachuk AP; Azev VN; Lipkin VM; Myasoedov NF
    J Psychopharmacol; 2016 Sep; 30(9):922-35. PubMed ID: 27464742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice].
    Sarkisova KIu; Kozlovskiĭ II; Kozlovskaia MM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(2):226-37. PubMed ID: 18661785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dynamics of behavioral and neuroreceptor effects after acute and long-term noopept administration in C57BL/6 and BALB/c mice].
    Kovalev GI; Kondrakhin EA; Salimov RM; Neznamov GG
    Eksp Klin Farmakol; 2014; 77(12):3-9. PubMed ID: 25739185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in expression of the genes for chemokines, cytokines, and their receptors in response to selank and its fragments].
    Kolomin TA; Shadrina MI; Slominskiĭ PA; Limborskaia S; Miasoedov NF
    Genetika; 2011 May; 47(5):711-4. PubMed ID: 21786679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice.
    Akillioglu K; Binokay S; Kocahan S
    Behav Brain Res; 2012 Jul; 233(1):157-61. PubMed ID: 22562039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats.
    Kozlovskii II; Danchev ND
    Neurosci Behav Physiol; 2003 Sep; 33(7):639-43. PubMed ID: 14552529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
    Kolik LG; Nadorova AV; Antipova TA; Kruglov SV; Kudrin VS; Durnev AD
    Bull Exp Biol Med; 2019 Sep; 167(5):641-644. PubMed ID: 31625062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.
    Kasian A; Kolomin T; Andreeva L; Bondarenko E; Myasoedov N; Slominsky P; Shadrina M
    Behav Neurol; 2017; 2017():5091027. PubMed ID: 28280289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation.
    Kolik LG; Nadorova AV; Kozlovskaya MM
    Bull Exp Biol Med; 2014 May; 157(1):52-5. PubMed ID: 24913576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Connectomic Approach to Studying Selank and Semax Effects.
    Panikratova YR; Lebedeva IS; Sokolov OY; Rumshiskaya AD; Kupriyanov DA; Kost NV; Myasoedov NF
    Dokl Biol Sci; 2020 Jan; 490(1):9-11. PubMed ID: 32342318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions.
    Sokolov OY; Meshavkin VK; Kost NV; Zozulya AA
    Bull Exp Biol Med; 2002 Feb; 133(2):133-5. PubMed ID: 12432865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of nootropic drugs on behavior of BALB/c and C57BL/6 mice in the exploratory cross-maze test].
    Vasil'eva EV; Salimov RM; Kovalev GI
    Eksp Klin Farmakol; 2012; 75(7):3-7. PubMed ID: 23025044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice.
    Kolik LG; Nadorova AV; Seredenin SB
    Bull Exp Biol Med; 2016 Nov; 162(1):56-59. PubMed ID: 27878720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimizing action of synthetic peptide Selank on active avoidance conditioning test in rats].
    Kozlovskiĭ II; Danchev ND
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2002; 52(5):579-84. PubMed ID: 12449836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits?
    Verleye M; Dumas S; Heulard I; Krafft N; Gillardin JM
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):457-70. PubMed ID: 20943351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.